{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:50:22Z","timestamp":1791521422305,"version":"4.3.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We describe a case of a patient with multiple sclerosis (MS) stable on natalizumab who developed widespread gadolinium-enhancing lesions and clinical relapse seven and eight months after gamma knife radiosurgery (GKRS) for left cerebellar convexity meningioma. We explore how increased blood\u2013brain barrier (BBB) permeability post-GKRS could potentially interfere with the lymphocyte anti-trafficking effect of natalizumab and result in new central nervous system (CNS) inflammation distant from the radiation site.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Comprehensive analysis of the patient\u2019s chart, brain and spine imaging, serum and cerebrospinal fluid (CSF) profiles was conducted. We compiled a graphical representation of treatment changes, radiologic findings, and GKRS initiation within one timeframe. We conducted a structured literature review to support the discussion of this case and hypothesize possible pathophysiological mechanisms contributing to clinical and radiological findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven months after GKRS, follow-up brain magnetic resonance imaging (MRI) demonstrated multiple gadolinium-enhancing lesions in both cerebral hemispheres, and repeat imaging one month later revealed new gadolinium-enhancing lesions, correlating with the patient\u2019s clinical relapse. Alternative causes of disease progression, including radiation-induced demyelination, radionecrosis, opportunistic infections, progressive multifocal leukoencephalopathy (PML), and development of anti-natalizumab antibodies, were explored and considered less likely. The patient was switched to ofatumumab with subsequent clinical and radiological stability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Given extensive new inflammatory lesions far from the GKRS site, it seems unlikely that the sole mechanism was radiation-induced neurotoxicity. We hypothesize that late delayed radiation side effects caused by GKRS may have enabled peripheral lymphocytes to enter the CNS, counteracting the effects of natalizumab on blocking lymphocyte trafficking through the BBB and possibly contributing to MS relapse.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1959731","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:26:14Z","timestamp":1791519974000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiple sclerosis relapse following gamma knife radiosurgery for meningioma in a patient treated with natalizumab: case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Maryna","family":"Turbinska","sequence":"first","affiliation":[{"name":"Division of Neurology, University of Alberta","place":["Edmonton, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeela","family":"Nathoo","sequence":"additional","affiliation":[{"name":"Division of Neurology, University of Alberta","place":["Edmonton, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Smyth","sequence":"additional","affiliation":[{"name":"Division of Neurology, University of Alberta","place":["Edmonton, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-019-01144-x","article-title":"Efficacy and safety of gamma knife radiosurgery for posterior cranial fossa meningioma: a systematic review","volume":"43","author":"Jumah","year":"2020","journal-title":"Neurosurg Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003702","article-title":"The 35-year evolution of stereotactic radiosurgery for meningiomas","volume":"98","author":"Wei","year":"2026","journal-title":"Neurosurgery"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2012.00073","article-title":"Radiation-induced brain injury: a review","volume":"2","author":"Greene-Schloesser","year":"2012","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.02.056","article-title":"Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular diseases or multiple sclerosis","volume":"81","author":"Lowell","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.06.014","article-title":"Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience","volume":"66","author":"Miller","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61299-X","article-title":"CNS complications of radiotherapy and chemotherapy","volume":"374","author":"Soussain","year":"2009","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13247554","article-title":"Multiple sclerosis-like lesions induced by radiation: a case report and systematic review of the literature","volume":"13","author":"Sterpi","year":"2024","journal-title":"J Clin Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-025-02432-w","article-title":"Incidence of radiation necrosis following different radiotherapy fractionation schedules for intracranial meningiomas","author":"Pali\u010dka","year":"2026","journal-title":"Strahlenther Onkol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-015-1911-1","article-title":"Post-radiosurgical edema associated with parasagittal and parafalcine meningiomas: a multicenter study","volume":"125","author":"Sheehan","year":"2015","journal-title":"J Neuro-Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1148\/rg.2021200064","article-title":"Recognizing radiation-induced changes in the central nervous system: where to look and what to look for","volume":"41","author":"Katsura","year":"2021","journal-title":"Radiographics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.03.026","article-title":"Radiation-induced edema after single-fraction or multifraction stereotactic radiosurgery for non-base of skull meningiomas","volume":"101","author":"Milano","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1575653","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy","volume":"16","author":"Glenn","year":"2025","journal-title":"Front Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7145","article-title":"MRI shrimp sign in cerebellar progressive multifocal leukoencephalopathy: description and validation of a novel observation","volume":"42","author":"Adra","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1148\/rg.272065155","article-title":"Patterns of contrast enhancement in the brain and meninges","volume":"27","author":"Smirniotopoulos","year":"2007","journal-title":"RadioGraphics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199906000-00006","article-title":"Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain","volume":"58","author":"Proescholdt","year":"1999","journal-title":"J Neuropathol Exp Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/63.5.474","article-title":"Intercellular adhesion molecule-1 and blood-spinal cord barrier disruption in central nervous system radiation injury","volume":"63","author":"Nordal","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2026.106896","article-title":"Cell adhesion molecules in traumatic brain injury: orchestrating leukocyte infiltration, BBB disruption, and neuroinflammation","volume":"138","author":"Barrios Lizon","year":"2026","journal-title":"Brain Behav Immun"},{"key":"B18","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41573-022-00477-5","article-title":"Thinking outside the box: non-canonical targets in multiple sclerosis","volume":"21","author":"Bierhansl","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S1537-1891(02)00199-4","article-title":"Lymphocyte migration into the central nervous system: implication of ICAM-1 signalling at the blood-brain barrier","volume":"38","author":"Greenwood","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2026.101176","article-title":"Impact of modern central nervous system radiation on multiple sclerosis relapse and progression","volume":"59","author":"Zhao-Fleming","year":"2026","journal-title":"Clin Transl Radiat Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25219","article-title":"Permeability of the blood\u2013brain barrier predicts no evidence of disease activity at 2 years after natalizumab or fingolimod treatment in relapsing\u2013remitting multiple sclerosis","volume":"83","author":"Cramer","year":"2018","journal-title":"Ann Neurol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70110-8","article-title":"Getting specific: monoclonal antibodies in multiple sclerosis","volume":"7","author":"Lutterotti","year":"2008","journal-title":"Lancet Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-023-02797-8","article-title":"High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4+ T cell arrest on the inflamed blood\u2013brain barrier under flow in vitro","volume":"20","author":"Soldati","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1004795","article-title":"Anti-CD20 therapies in multiple sclerosis: from pathology to the clinic","volume":"14","author":"De S\u00e8ze","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1959731\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:26:15Z","timestamp":1791519975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1959731\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,9]]},"references-count":24,"alternative-id":["10.3389\/fonc.2026.1959731"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1959731","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,9]]},"article-number":"1959731"}}